Release date: 2017-05-22
Body Vision Medical is a medical device company that specializes in the development of in vivo navigation systems for the minimally invasive diagnosis and treatment of lung cancer using enhanced real-time imaging technology. Recently, the company announced that its lung vision navigation system, LungVision, has been approved by the US Food and Drug Administration (FDA) as a new imaging system for accurate real-time navigation and lesion localization during pulmonary bronchoscopy. .
LungVision is the first product based on the company's Body Vision platform and has achieved outstanding results in several multi-center clinical studies conducted in the United States. LungVision utilizes a sophisticated, enhanced real-time approach that enables clinicians to plan, visualize, and track intrabronchial tools and radiolucent lesions in real time. LungVision's collaborative imaging system incorporates preoperative three-dimensional (3D) high-resolution imaging (such as computed tomography [CT]) into intraoperative fluoroscopy.
In clinical practice, Body Vision technology provides minimally invasive, real-time lesion localization and navigation, and seamless integration with a variety of clinical environments and clinical tools, while significantly reducing operational time and cost.
Kyle Hogarth, MD, one of the first LungVison users in North America and the bronchoscopy department director and associate professor of medicine at the University of Chicago, said that the unique technology developed by Body Vision combines the intelligence of navigation with the simplicity of perspective to effectively locate And significantly improve lung biopsy, this technology will upgrade our standard methods used in clinical practice.
Dorian Averbuch, CEO of Body Vision, said that we are very excited to push the Body Vision platform to the medical world. We envision that in the near future, the LungVision system will revolutionize the way clinicians diagnose and treat peripheral lung lesions.
The first clinical practice experience using the LungVision system will be announced at the American Thoracic Society (ATS) meeting at the Washington Convention Center on May 19-24.
references:
1. FDA Clears Body Vision Medical's LungVision Navigation System, Revolutionizing Lung Cancer Detection and Treatment
2, Body Vision Medical official website
Source: Sina Pharmaceutical News
Jiangsu Tiera Biotechnology Co., Ltd , https://www.tierabio.com